Aleafia Health (AH.TO) Stock Price
Aleafia Health Price
Over the last 7 years Aleafia Health grew revenue by 54.1% annually, reaching 42.85 M CAD. For Aleafia Health, the net margin of -80.8% is up versus -242.2% a few years ago.
Aleafia Health stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Aleafia Health business model & stock analysis
Frequently asked questions about Aleafia Health
The business model of Aleafia Health Inc. revolves around the provision of medical cannabis products, services, and education. As a leading Canadian cannabis company, Aleafia Health focuses on vertically integrating its operations, spanning the entire cannabis value chain. By cultivating high-quality cannabis strains, the company ensures a consistent supply of medical-grade cannabis. Aleafia Health operates medical cannabis clinics where patients receive personalized treatment plans and have access to a wide range of cannabis products. Through its education and training initiatives, Aleafia Health aims to enhance understanding and awareness of medical cannabis among healthcare practitioners.
Aleafia Health Inc is primarily active in the healthcare and cannabis industry.
The main competitors of Aleafia Health Inc in the market include Canopy Growth Corporation, Aurora Cannabis Inc, and Cronos Group Inc.
Aleafia Health Inc is a leading Canadian cannabis company that specializes in producing and distributing high-quality medical cannabis products. Founded in 2007, the company has built a solid reputation for its commitment to patient care and providing innovative treatment options. With its headquarters in Concord, Ontario, Aleafia Health operates a network of medical cannabis clinics across Canada. The company focuses on both cultivation and research to develop effective cannabis strains for various medical conditions. Aleafia Health is dedicated to advancing the science and understanding of cannabis and its therapeutic benefits, offering patients a reliable and trusted source for their medical cannabis needs.
Aleafia Health Inc. has achieved several significant milestones since its establishment. Notably, the company expanded its production capacity by acquiring the Niagara Greenhouse facility. Moreover, Aleafia Health Inc. successfully launched its medical cannabis clinic network, which has rapidly grown to become one of the largest nationwide. Additionally, the company entered into a strategic partnership with Emblem Corp. to establish a leading Canadian medical cannabis brand. Furthermore, Aleafia Health Inc. was listed on the Toronto Stock Exchange in 2018, demonstrating its commitment to providing value to its shareholders. These milestones reflect Aleafia Health Inc.'s dedication towards growth, innovation, and becoming a reputable player in the cannabis industry.
Aleafia Health Inc is primarily present in Canada.
Aleafia Health Inc represents a commitment to providing quality healthcare solutions and improving the well-being of patients. The company follows a patient-centric approach, placing great emphasis on holistic care and personalized treatment options. Aleafia Health Inc focuses on creating innovative medical cannabis therapies, supported by cutting-edge research and development. With a strong dedication to advancing the medical cannabis industry, Aleafia Health Inc aims to provide accessible and high-quality healthcare products for patients worldwide. The company's corporate philosophy revolves around transparency, integrity, and collaboration to foster a nurturing and supportive environment for patients and stakeholders.
8 analysts currently rate the Aleafia Health stock: 0 recommend buying, 3 holding and 5 selling.
The Aleafia Health share (AH.TO) is listed on 6 stock exchanges, including: Toronto (AH.TO), Frankfurt (ARAH.F), München (ARAH.MU), Düsseldorf (ARAH.DU), Hamburg (ARAH.HM).
Aleafia Health Inc is a Canadian company that operates in the cannabis industry. Its business model is focused on providing high-quality medical cannabis products and services. One key aspect is the vertical integration model, which means that the company operates from cultivation to sales of cannabis products. One of the main suppliers, Aleafia Farms, has a cultivation area of approximately 22 hectares. The plants are grown optimally and include the production of dry herb and oil extraction. The focus is on producing medical products to improve patient health. The company exclusively works with organically grown and sustainable cannabis. Another part of the business model is providing healthcare services and products to patients in need of medical cannabis treatment. Aleafia Health offers everything from clinical services to developing online platforms for medical diagnostics. The company has a team of medical professionals who examine patients, analyze medical data, and provide recommendations for dosing cannabis products. The products sold include pills, oils, tinctures, and lozenges, with various dosing methods depending on the individual patient's needs. Aleafia's main goal is to improve patient health and support modern medicine through the use of cannabis products. They reduce pain perception, improve symptoms of PTSD and ADD, and enhance appetite and nausea stimulation in patients. Customers of Aleafia Health Inc have access to a wide range of top-quality medical products and services. The company aims to increase its reach and product benefits through partnerships with other healthcare organizations. In conclusion, Aleafia Health Inc's business model is focused on producing high-quality medical cannabis products and providing top-notch healthcare services. The company operates one of the most comprehensive vertically integrated cannabis supply chains in Canada and emphasizes the use of quality, organically grown plants. They offer customers a wide range of products and services with various dosing methods and collaborate closely with healthcare specialists to achieve the best therapeutic outcomes for patients. Aleafia Health strives to strengthen its position as a leading company in the medical cannabis industry.
The revenue cannot currently be calculated for Aleafia Health.
The profit cannot currently be calculated for Aleafia Health.
The P/E ratio cannot be calculated for Aleafia Health at the moment.
The P/S cannot be calculated for Aleafia Health currently.
The Eulerpool Quality Score for Aleafia Health is 4/10.
The ISIN of Aleafia Health is CA01444Q1046. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Aleafia Health is A2JHC5. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Aleafia Health is AH.TO. The ticker symbol is used to trade Aleafia Health shares on the stock exchange.
Aleafia Health stock
Aleafia Health Peer Group
Aleafia Health Ticker
Aleafia Health FIGI
All fundamentals and in-depth analysis of Aleafia Health
Our stock analysis for Aleafia Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aleafia Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.